Search
for
Sort by
Research 61–90 of 1000+
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Markers of inflammation, metabolic disorders, and principles of treatment for alopecia areata in children
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- Treatment of severe alopecia areata with baricitinib
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Application of Baricitinib in Dermatology
- Rapidly progressive alopecia areata totalis in a COVID‐19 patient, unresponsive to tofacitinib
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- Sudden improvement of alopecia universalis and psoriatic arthritis while receiving upadacitinib: a case-based review
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- LB785 Efficacy and safety of baricitinib in adults with Alopecia Areata: Phase 3 results from a randomized controlled trial (BRAVE-AA1)
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Treatment of Steroid-Resistant Beard-Restricted Alopecia Areata with Baricitinib
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2
- Janus kinase inhibition for the treatment of refractory frontal fibrosing alopecia: A case series and review of the literature
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Ruxolitinib for the treatment of severe alopecia areata